Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa

The Metabolic Syndrome is a disease entity characterized by the joint presence of several metabolic and vascular disturbances (hypertension, central obesity, diabetes and dyslipidemia), whose prevalence increases with age, which is very closely related to the development of atherosclerosis. The shor...

Full description

Bibliographic Details
Main Authors: Montero, L. (Laura), Zalba, G. (Guillermo)
Format: info:eu-repo/semantics/doctoralThesis
Language:spa
Published: Universidad de Navarra 2013
Subjects:
Online Access:https://hdl.handle.net/10171/28134
_version_ 1793400608115392512
author Montero, L. (Laura)
Zalba, G. (Guillermo)
author_facet Montero, L. (Laura)
Zalba, G. (Guillermo)
author_sort Montero, L. (Laura)
collection DSpace
description The Metabolic Syndrome is a disease entity characterized by the joint presence of several metabolic and vascular disturbances (hypertension, central obesity, diabetes and dyslipidemia), whose prevalence increases with age, which is very closely related to the development of atherosclerosis. The shortening of telomere length in leukocytes, which is used as a marker of aging, has been associated with the cardiovascular risk factors included in the definition of Metabolic Syndrome, with insulin resistance promoting their shortening. The simultaneous presence of these factors leads to increased oxidative stress mediated by the phagocytic NADPH oxidase, as reflected in the increased levels of oxidative stress marker TBARS, which accelerates the erosion of telomeres primarily through telomeric DNA oxidation. Thus, NADPH oxidase overactivity promotes telomere shortening in Metabolic Syndrome and insulin resistant patients, and increases the risk of vascular complications, as shown by the greater prevalence of several surrogate markers atherothrombotic risk (carotid intima-media thickness and metalloproteinase-9) in these patients. The involvement of the NADPH oxidase in this process is supported by in vitro findings in cultured murine macrophages Finally, our in vivo and in vitro results underline a relevant role for hyperglycemia in the telomere shortening by promoting NADPH oxidase-dependent oxidative stress.
format info:eu-repo/semantics/doctoralThesis
id oai:dadun.unav.edu:10171-28134
institution Universidad de Navarra
language spa
publishDate 2013
publisher Universidad de Navarra
record_format dspace
spelling oai:dadun.unav.edu:10171-281342020-03-03T20:24:34Z Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa Montero, L. (Laura) Zalba, G. (Guillermo) Materias Investigacion::Ciencias de la vida::Bioquímica Fisiología cardiovascular Biología molecular The Metabolic Syndrome is a disease entity characterized by the joint presence of several metabolic and vascular disturbances (hypertension, central obesity, diabetes and dyslipidemia), whose prevalence increases with age, which is very closely related to the development of atherosclerosis. The shortening of telomere length in leukocytes, which is used as a marker of aging, has been associated with the cardiovascular risk factors included in the definition of Metabolic Syndrome, with insulin resistance promoting their shortening. The simultaneous presence of these factors leads to increased oxidative stress mediated by the phagocytic NADPH oxidase, as reflected in the increased levels of oxidative stress marker TBARS, which accelerates the erosion of telomeres primarily through telomeric DNA oxidation. Thus, NADPH oxidase overactivity promotes telomere shortening in Metabolic Syndrome and insulin resistant patients, and increases the risk of vascular complications, as shown by the greater prevalence of several surrogate markers atherothrombotic risk (carotid intima-media thickness and metalloproteinase-9) in these patients. The involvement of the NADPH oxidase in this process is supported by in vitro findings in cultured murine macrophages Finally, our in vivo and in vitro results underline a relevant role for hyperglycemia in the telomere shortening by promoting NADPH oxidase-dependent oxidative stress. 2013-03-15T12:18:02Z 2013-03-15T12:18:02Z 2013-03-15 2012-12-20 info:eu-repo/semantics/doctoralThesis https://hdl.handle.net/10171/28134 spa info:eu-repo/semantics/openAccess application/pdf Universidad de Navarra
spellingShingle Materias Investigacion::Ciencias de la vida::Bioquímica
Fisiología cardiovascular
Biología molecular
Montero, L. (Laura)
Zalba, G. (Guillermo)
Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa
title Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa
title_full Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa
title_fullStr Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa
title_full_unstemmed Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa
title_short Estrés oxidativo y acortamiento de los telómeros en pacientes con Síndrome Metabólico: papel de la NADPH oxidasa
title_sort estrés oxidativo y acortamiento de los telómeros en pacientes con síndrome metabólico: papel de la nadph oxidasa
topic Materias Investigacion::Ciencias de la vida::Bioquímica
Fisiología cardiovascular
Biología molecular
url https://hdl.handle.net/10171/28134
work_keys_str_mv AT monterollaura estresoxidativoyacortamientodelostelomerosenpacientesconsindromemetabolicopapeldelanadphoxidasa
AT zalbagguillermo estresoxidativoyacortamientodelostelomerosenpacientesconsindromemetabolicopapeldelanadphoxidasa